{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T16:00:06Z","timestamp":1791734406270,"version":"4.3.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2025C01217"],"award-info":[{"award-number":["2025C01217"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Shandong Province Natural Science Foundation","doi-asserted-by":"publisher","award":["ZR2023ZD59"],"award-info":[{"award-number":["ZR2023ZD59"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2023\\u2013PT320\\u201302"],"award-info":[{"award-number":["2023\\u2013PT320\\u201302"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303786"],"award-info":[{"award-number":["82303786"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073296"],"award-info":[{"award-number":["82073296"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273490"],"award-info":[{"award-number":["82273490"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.actbio.2025.07.035","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T15:52:18Z","timestamp":1752681138000},"page":"535-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapy"],"prefix":"10.1016","volume":"203","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6234-6558","authenticated-orcid":false,"given":"Kewei","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9785-1569","authenticated-orcid":false,"given":"Zichong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hengyan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6370-9728","authenticated-orcid":false,"given":"Hangxiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10151","key":"10.1016\/j.actbio.2025.07.035_bib0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.actbio.2025.07.035_bib0002","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1080\/15384047.2019.1640032","article-title":"Current state of melanoma diagnosis and treatment","volume":"20","author":"Davis","year":"2019","journal-title":"Cancer Biol. Ther."},{"issue":"10400","key":"10.1016\/j.actbio.2025.07.035_bib0003","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"issue":"9687","key":"10.1016\/j.actbio.2025.07.035_bib0004","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0140-6736(09)61397-0","article-title":"Cutaneous melanoma in the era of molecular profiling","volume":"374","author":"Thompson","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0005","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","article-title":"Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.actbio.2025.07.035_bib0006","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ccell.2023.03.010","article-title":"Prior anti-CTLA-4 therapy impacts molecular characteristics associated with anti-PD-1 response in advanced melanoma","volume":"41","author":"Campbell","year":"2023","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.actbio.2025.07.035_bib0007","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.actbio.2025.07.035_bib0008","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.actbio.2025.07.035_bib0009","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41568-022-00442-9","article-title":"Mechanisms of immune activation and regulation: lessons from melanoma","volume":"22","author":"Kalaora","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.actbio.2025.07.035_bib0010","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-23-3511","article-title":"Ionizable STING-activating nanoadjuvants enhance tumor immunogenicity and potentiate immunotherapy efficacy in solid tumors","volume":"84","author":"Xian","year":"2024","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.actbio.2025.07.035_bib0011","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrd3137","article-title":"Targeting mitochondria for cancer therapy","volume":"9","author":"Fulda","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"3","key":"10.1016\/j.actbio.2025.07.035_bib0012","first-page":"555","volume":"166","author":"Vyas","year":"2016","journal-title":"Mitochondria Cancer Cell"},{"issue":"5","key":"10.1016\/j.actbio.2025.07.035_bib0013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/ni.3704","article-title":"Mitochondria are the powerhouses of immunity","volume":"18","author":"Mills","year":"2017","journal-title":"Nat. Immunol."},{"issue":"10","key":"10.1016\/j.actbio.2025.07.035_bib0014","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/nri.2017.66","article-title":"Mitochondrial control of immunity: beyond ATP","volume":"17","author":"Mehta","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"7329","key":"10.1016\/j.actbio.2025.07.035_bib0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0016","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cell.2016.05.035","article-title":"Mitochondrial dynamics controls T cell fate through metabolic programming","volume":"166","author":"Buck","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0017","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cmet.2016.06.007","article-title":"Mitochondrial biogenesis and proteome remodeling promote one-carbon metabolism for T cell activation","volume":"24","author":"Ron-Harel","year":"2016","journal-title":"Cell Metab."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0018","doi-asserted-by":"crossref","first-page":"7664","DOI":"10.1038\/s41467-024-51945-y","article-title":"Mitochondrial rewiring with small-molecule drug-free nanoassemblies unleashes anticancer immunity","volume":"15","author":"Ren","year":"2024","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.actbio.2025.07.035_bib0019","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrd.2018.174","article-title":"Mitochondria as a therapeutic target for common pathologies","volume":"17","author":"Murphy","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"19","key":"10.1016\/j.actbio.2025.07.035_bib0020","article-title":"Image-guided TME-improving nano-platform for Ca(2+) signal disturbance and enhanced tumor PDT","volume":"10","author":"Jiang","year":"2021","journal-title":"Adv Heal. Mater"},{"issue":"43","key":"10.1016\/j.actbio.2025.07.035_bib0021","article-title":"Mito-Bomb: targeting mitochondria for cancer therapy","volume":"33","author":"Guo","year":"2021","journal-title":"Adv. Mater."},{"issue":"16","key":"10.1016\/j.actbio.2025.07.035_bib0022","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202300354","article-title":"Bimodal antimicrobial surfaces of phytic acid-prussian blue nanoparticles-cationic polymer networks","volume":"10","author":"He","year":"2023","journal-title":"Adv. Sci."},{"issue":"11","key":"10.1016\/j.actbio.2025.07.035_bib0023","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41571-020-0410-2","article-title":"Clinical development and potential of photothermal and photodynamic therapies for cancer","volume":"17","author":"Li","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.actbio.2025.07.035_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121875","article-title":"Advanced techniques for performing photodynamic therapy in deep-seated tissues","volume":"291","author":"Sun","year":"2022","journal-title":"Biomaterials"},{"issue":"4","key":"10.1016\/j.actbio.2025.07.035_bib0025","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1158\/0008-5472.CAN-21-4122","article-title":"Forging forward in photodynamic therapy","volume":"82","author":"Cramer","year":"2022","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.actbio.2025.07.035_bib0026","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210385120","article-title":"Photoactivatable nanoagonists chemically programmed for pharmacokinetic tuning and in situ cancer vaccination","volume":"120","author":"Wan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"23","key":"10.1016\/j.actbio.2025.07.035_bib0027","doi-asserted-by":"crossref","first-page":"14877","DOI":"10.1021\/acsnano.3c08425","article-title":"Syringeable near-infrared light-activated In situ immunogenic hydrogel boosts the cancer-immunity cycle to enhance anticancer immunity","volume":"18","author":"Fu","year":"2024","journal-title":"ACS. Nano"},{"issue":"31","key":"10.1016\/j.actbio.2025.07.035_bib0028","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202101155","article-title":"Acidity-activatable dynamic nanoparticles boosting ferroptotic cell death for immunotherapy of cancer","volume":"33","author":"Song","year":"2021","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0029","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1038\/s41467-023-40996-2","article-title":"A photo-triggered self-accelerated nanoplatform for multifunctional image-guided combination cancer immunotherapy","volume":"14","author":"Kang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.actbio.2025.07.035_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121433","article-title":"Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy","volume":"282","author":"Zhang","year":"2022","journal-title":"Biomaterials"},{"issue":"28","key":"10.1016\/j.actbio.2025.07.035_bib0031","article-title":"A photo-activated continuous reactive oxygen species nanoamplifier for dual-dynamic cascade cancer therapy","volume":"12","author":"Zhang","year":"2023","journal-title":"Adv Heal. Mater"},{"issue":"7","key":"10.1016\/j.actbio.2025.07.035_bib0032","doi-asserted-by":"crossref","first-page":"10242","DOI":"10.1021\/acsnano.1c08008","article-title":"Targeting the mitochondria with pseudo-stealthy nanotaxanes to impair mitochondrial biogenesis for effective cancer treatment","volume":"16","author":"Ren","year":"2022","journal-title":"ACS. Nano"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0033","doi-asserted-by":"crossref","DOI":"10.14440\/jbm.2014.12","article-title":"A stepwise procedure for isolation of murine bone marrow and generation of dendritic cells","volume":"1","author":"Madaan","year":"2014","journal-title":"J. Biol. Methods"},{"issue":"9","key":"10.1016\/j.actbio.2025.07.035_bib0034","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"issue":"28","key":"10.1016\/j.actbio.2025.07.035_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202404296","article-title":"Smart nanoassembly enabling activatable NIR fluorescence and ROS generation with enhanced tumor penetration for imaging-guided photodynamic therapy","volume":"36","author":"Chen","year":"2024","journal-title":"Adv. Mater."},{"issue":"4","key":"10.1016\/j.actbio.2025.07.035_bib0036","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.cell.2005.02.001","article-title":"Mitochondria, oxidants, and aging","volume":"120","author":"Balaban","year":"2005","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0037","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1038\/s41467-019-11269-8","article-title":"Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.actbio.2025.07.035_bib0038","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.actbio.2025.07.035_bib0039","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40824-018-0133-y","article-title":"New opportunities for nanoparticles in cancer immunotherapy","volume":"22","author":"Park","year":"2018","journal-title":"Biomater. Res."},{"issue":"9","key":"10.1016\/j.actbio.2025.07.035_bib0040","article-title":"Immune checkpoint inhibitor-based strategies for synergistic cancer therapy","volume":"10","author":"He","year":"2021","journal-title":"Adv Heal. Mater"},{"issue":"6382","key":"10.1016\/j.actbio.2025.07.035_bib0041","first-page":"1350","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science (1979)"},{"issue":"8","key":"10.1016\/j.actbio.2025.07.035_bib0042","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/s43018-021-00232-6","article-title":"Mature tertiary lymphoid structures predict immune checkpoint inhibitor efficacy in solid tumors independently of PD-L1 expression","volume":"2","author":"Vanhersecke","year":"2021","journal-title":"Nat. Cancer"},{"issue":"2","key":"10.1016\/j.actbio.2025.07.035_bib0043","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41416-020-01048-4","article-title":"Cytotoxic CD8(+) T cells in cancer and cancer immunotherapy","volume":"124","author":"Raskov","year":"2021","journal-title":"Br. J. Cancer"}],"updated-by":[{"DOI":"10.1016\/j.actbio.2025.11.029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000}},{"DOI":"10.1016\/j.actbio.2025.11.029","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000}}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612500532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270612500532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:22:22Z","timestamp":1772760142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270612500532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":43,"alternative-id":["S174270612500532X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2025.07.035","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mitochondria-targeting pseudo-stealthy nanophotosensitizer as a potent immunogenic cell death inducer to unleash the cancer-immunity cycle for melanoma therapy","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2025.07.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Acta Materialia Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}